MB"), specific
for this isoenzyme, to Sepharose 4B. Heart tissue is homogenized and fractionated with 40-70% saturated ammonium sulfate before it is applied to the immunoafflnity gel. CK-MB activity, retained on the gel, is then eluted with a high-pH diethylamine buffer (0.1 mol/L, pH 10.5). The purified CK-MB isoenzyme is stabilized by collection directly into tubes containing glycerol (to prevent dissociation of the enzyme subunits) and pH-neutralizing buffer. This procedure compares favorably in yield, specific activity, and technical ease with a multi-column purification method previously used in our laboratory.
We have used the immunoaffinity pr#{244}ce-dure to purify to homogeneity CK-MB from human, dog, and rabbit heart, with yields of 50 involve multiple column-purification steps, are long and tedious, and may result in poor yields and low specific activities.
We have produced a monoclonal antibody ("Conan-MB") that is specific for the CK-MB-isoenzyme (9) and does not react with CK-MM or CK-BB. We have used it to develop a direct assay for CK-MB activity in serum (10), and have found it also to be useful in the purification of CK-MB.
Here we present a rapid tl ee-step immunoaffinity procedure and show it to be suitable for purification of CK-MB from human, dog, or rabbit heart. 
Materials and Methods

Development
Of the CK-MB activity applied, 71% was recovered in this
eluate with no evidence of subunit dissociation ( Figure  2 ). After optimizing the elution conditions to produce pure and stable CK-MB isoenzyme, we tested the possibility of applying heart homogenate directly to the immunoaftlnity column.
A homogenate of human heart was divided into two aliquota, one of which was subjected to fractionation with 40-70% saturated ainmonium sulfate. Both aliquots were made 0.5 mol/L in NaC1, centrifuged at 20 000 x g for 30 min, and applied to a 5-mL column of immunoafilnity gel. Several problems in using the unfractionated homogenate became apparent.
There was considerable nonspecific binding, as evidenced by a discoloration of the column, which remained even after washing and eluting. Also, the eluted fractions were cloudy, and specific activity was low (273 kU/g as compared with 588 kU/g when the ammonium k sulfate fraction was used as the starting material). We therefore chose to include the ammonium sulfate fractionation step as a routine part of our purification procedure. We also assessed the influence of NaCl and flow rates on the immunoaffinity purification procedure. NaCl is generally added to samples and washing buffer in immunopurification procedures to minimize nonspecific adsorption (18). However, we have observed decreased CK activity when NaC1 is added (data not shown) and, therefore, do not add it to the preparations, before they are applied to the column, or to the washing buffer. We have noticed no problem with nonspecific binding. We load the column at a flow rate of 30 mL/h and rerun the effluent over the column a second time to maximize binding. More than 90% of the CK-MB activity can be accounted for under these loading and washing conditions.
Method Comparison
We compared the immunoaffinity purification method with the purification procedure previously used in our laboratory (see Table 1 ). Human heart tissue (334 g) was processed through the first two steps: homogenization and fractionation with ammonium sulfate. We then divided the preparation, applying half to the immunoaffinity column and subjecting the other half to DEAE-Sepharose chromatography to separate the CK-isoenzymes, 5'-AMP affinity chromatography to remove contaminating lactate dehydro- 
DEAE-Sepharose ii
'CX activity measured at 37#{176}C in a Flexigem centrifugal analyzer. b Specific activity calculated for steps where CK-MB was the only isoenzyme detectable by electrophoresis on agarose gel. 0334 g of heart tissue was homogenized and fractionated with ammonium sulfate, then divided into two equal aliquots for further purification. as assessed by electrophoresis on agarose gel (data not shown).
Other Tissues
After determining conditions for purification of CK-MB from human heart tissue, we applied the same procedure to dog and rabbit heart (408 and 363 g, respectively) ( Figure  3 ) and electrophoresis on agarose gel (data not shown).
Competitive AlA
We compared the ability of IP-CK-MB from human, dog, and rabbit to compete of dog heart and 363 g of rabbit heart were used.
The rabbit CK-MB was 10-fold less effective in displacing 1251-labeled human CK-MB, the B50 being 6 g. We thank Dr. Moon Nahm for sharing his procedure for the preparation of the immunoaffinity gel. This work was supported in part by NIH training grant 2 T32
DIscussion
ES07066-09
(H.C.V.).
